and REAP-seq (RNA expression and protein sequencing assay) to investigate the relationship between RNA transcripts and proteins, and identify new cell types and cell states associated with disease.

In fact, when we applied for accreditation from the CAP (College of American Pathologists), we worked with them to create the first whole-transcriptome sequencing activity as a reportable assay." ...

PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a newly published study in Nature Communications unveiling a powerful new method for ...

One of the major challenges that scientists face while using DNA barcoding techniques for high-throughput assays is labeling bias, which could lead to some sequencing features being over- or ...

DNA sequencing has been the gold-standard genotyping ... genotypic and phenotypic testing on a single patient sample. This assay, called PhenoSense GT, combines PhenoSense and GeneSeq testing ...

These include technology that can sequence a human genome for $100, highly sensitive imaging platforms for studying individual cells and subcellular compartments, and an assay system that facilitates ...

The "Molecular Diagnostics Patent Landscape Report" report has been added to ResearchAndMarkets.com's offering. The global ...

The Genomics Core now has an Illumina NextSeq500 Next Generation Sequencing (NGS) instrument ... and targeted and whole genome assays. The Genomic Core Laboratory has the capacity to provide a wide ...

The core runs the NextSeq500 and two MiSeq sequencers. Cost per samples varies depending on the assay, platform and sequencing length, as mentioned above. Many different samples can be multiplexed and ...

Global Genotyping Assay Market is valued at USD 14.36 Billion in 2022 and is projected to attain a value of USD 60.52 Billion by 2030 at a CAGR of 19.70% during the forecast period, 2022–2028. The ...